Plantar Fasciitis Clinical Trial
Official title:
Comparison of the Effectiveness of USG and Palpation Guidance Steroid Injection in Patients With Plantar Fasciitis
Verified date | October 2021 |
Source | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Plantar fasciitis, often described as overloading of the plantar fascia, is the most common cause of heel pain in adults. It is characterized by a sharp pain along the medial aspect of the heel, which is worse with the first step taken in the morning or at the beginning of an activity and decreases as the person warms up. The etiology of plantar fasciitis is multifactorial and not well understood. Poor biomechanics and changes in the structure of the foot can lead to repeated micro-trauma at the beginning of the plantar fascia, causing inflammation and degeneration. Plantar fasciitis is more common in sedentary individuals and athletes and those participating in running sports. Other risk factors associated with plantar fasciitis include reduced ankle dorsiflexion, increased body mass index (BMI), and work-related weight loss activities. Current treatments for plantar fasciitis, such as plantar fascia stretching exercises, strapping, extracorporeal shock wave therapy, nonsteroidal anti-inflammatory drugs (NSAIDs), arch braces, and heel pads are mainly aimed at reducing inflammation. Corticosteroid injections are usually reserved for refractory plantar fasciitis after conservative noninvasive attempts have failed. It has been shown to effectively reduce heel pain in patients with plantar fasciitis. The strong anti-inflammatory effect of corticosteroids can speed up the process of pain relief. In our study, we aimed to compare the effectiveness of USG and palpation guidance blind steroid injection in patients diagnosed with plantar fasciitis.
Status | Completed |
Enrollment | 66 |
Est. completion date | August 1, 2021 |
Est. primary completion date | June 1, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: 1. Patients diagnosed with plantar fasciitis 2. Between the ages of 18-75 3. Who have failed conservative treatment (stretching exercises, non-steroidal anti-inflammatory drugs and heel pads) for at least 3 months 4. Visual Anolog Scale value of 5 and above will be included in the study. Exclusion Criteria: 1. Having received any local injection therapy and physical therapy for heel pain within the last 4 months, 2. Any history of surgery for heel pain, tarsal tunnel syndrome, calcaneal fracture, Achilles tendinopathy, any deformity of the foot and ankle including pes, planus or pes cavus deformity 3. with systemic disorders such as diabetes mellitus, rheumatoid arthritis, hematological disease, or gout 4. Pregnancy 5. A recent history of aspirin or aspirin-like medication 6. mental disability |
Country | Name | City | State |
---|---|---|---|
Turkey | Adem ERBIROL | Isparta |
Lead Sponsor | Collaborator |
---|---|
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain Severity | visual analog scale (0-10) minimum score: 0 maximum score: 10. Higher scores reflect more severe pain. Higher values represent a worse outcome. | day 0 (before intervention) | |
Primary | Pain Severity | visual analog scale (0-10) minimum score: 0 maximum score: 10. Higher scores reflect more severe pain. Higher values represent a worse outcome. | 1 month after intervention | |
Primary | Pain Severity | visual analog scale (0-10) minimum score: 0 maximum score: 10. Higher scores reflect more severe pain. Higher values represent a worse outcome. | 3 month after intervention | |
Secondary | Foot Function Index | Foot Function Index(FFI) is a self-report questionnaire concerning foot function and pain. The FFI consists of 23 questions with scores 0-10 in three domains concerning foot pain, function and disability resulting in a total score range from 0 to 230. The score is validated for patients with plantar fasciitis with a minimal clinical important difference being 7 points. Higher values represent a worse outcome. | day 0 (before intervention) | |
Secondary | Foot Function Index | Foot Function Index(FFI) is a self-report questionnaire concerning foot function and pain. The FFI consists of 23 questions with scores 0-10 in three domains concerning foot pain, function and disability resulting in a total score range from 0 to 230. The score is validated for patients with plantar fasciitis with a minimal clinical important difference being 7 points. Higher values represent a worse outcome. | 1 month after intervention | |
Secondary | Foot Function Index | Foot Function Index(FFI) is a self-report questionnaire concerning foot function and pain. The FFI consists of 23 questions with scores 0-10 in three domains concerning foot pain, function and disability resulting in a total score range from 0 to 230. The score is validated for patients with plantar fasciitis with a minimal clinical important difference being 7 points. Higher values represent a worse outcome. | 3 month after intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02546115 -
RCT - Assessing the Benefits of the Use of a Tension Night Splint in Patients With Plantar Fasciitis
|
N/A | |
Unknown status |
NCT01882894 -
Efficacy of a Custom Temporary Foot Orthosis for Plantar Fasciitis Treatment
|
N/A | |
Terminated |
NCT01996111 -
Dehydrated Human Amnion/Chorion Membrane Micrografts(dHACM) Injectable in the Treatment of Recalcitrant Plantar Fasciitis
|
N/A | |
Completed |
NCT01659827 -
Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis
|
N/A | |
Completed |
NCT00888394 -
Effectiveness of Podiatry on Plantar Pain
|
Phase 4 | |
Completed |
NCT00758641 -
Platelet Rich Plasma to Treat Plantar Fasciitis
|
Phase 4 | |
Terminated |
NCT00527748 -
Foot and Ankle Range of Motion (Stretching) Apparatus
|
N/A | |
Recruiting |
NCT05584046 -
A Single-blind RCT to Investigate the Effect of a Novel Herbal Patch for the Treatment of PF
|
N/A | |
Completed |
NCT04088383 -
Amnios™ RT Outcomes Study
|
N/A | |
Completed |
NCT01994759 -
Optimal Treatment of Plantar Fasciitis: Physical Training, Glucocorticoid Injections or a Combination Thereof.
|
Phase 4 | |
Completed |
NCT02646579 -
Effects of Dry Needling Using Spinal and Peripheral Sites Versus Peripheral Sites Only
|
N/A | |
Completed |
NCT05592808 -
Comparison of Taping Techniques in Plantar Fasciitis
|
N/A | |
Not yet recruiting |
NCT04125264 -
Intense Therapeutic Ultrasound (ITU) to Treat Plantar Fasciitis
|
N/A | |
Completed |
NCT02546089 -
ABI v Dry Needling for Plantar Fasciitis
|
N/A | |
Completed |
NCT00765843 -
A Trial of Custom Foot Orthoses for the Treatment of Plantar Heel Pain
|
N/A | |
Completed |
NCT00155324 -
Change and Clinical Significance of Plantar Fascia Thickness After ESWT
|
N/A | |
Completed |
NCT04941469 -
Effectiveness of Specifically Optimized Off-the-counter Foot Orthosis for the Subtle Cavus Foot
|
N/A | |
Completed |
NCT06055933 -
Effect of Kinesio Taping and Extracorporeal Shock Wave Therapy on Plantar Fasciitis
|
||
Recruiting |
NCT02539082 -
the Safety and Efficacy of Collagen Injection in Patients With Plantar Fasciitis
|
Phase 4 | |
Enrolling by invitation |
NCT01786057 -
Effect of Extracorporeal Shock Wave Therapy of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis
|
Phase 2/Phase 3 |